According to Novavax's latest financial reports the company's current earnings (TTM) are -$0.53 B. an increase over its 2022 earnings that were of -$0.64 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$0.53 B | -16.59% |
2022 | -$0.64 B | -62.58% |
2021 | -$1.7 B | 320.54% |
2020 | -$0.41 B | 234.22% |
2019 | -$0.13 B | -30.17% |
2018 | -$0.18 B | 1.69% |
2017 | -$0.17 B | -36.44% |
2016 | -$0.27 B | 70.4% |
2015 | -$0.16 B | 89.27% |
2014 | -$82.79 M | 59.83% |
2013 | -$51.8 M | 81.9% |
2012 | -$28.48 M | 50.33% |
2011 | -$18.95 M | |
2009 | -$37.39 M | 8.8% |
2008 | -$34.36 M | 18.01% |
2007 | -$29.12 M | 18.33% |
2006 | -$24.61 M | 168.31% |
2005 | -$9.18 M | -62.51% |
2004 | -$24.47 M | 52.4% |
2003 | -$16.06 M | -28.21% |
2002 | -$22.36 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Novartis NVS | $9.43 B | -1,885.42% | ๐จ๐ญ Switzerland |
Pfizer PFE | $3.26 B | -718.03% | ๐บ๐ธ USA |
AstraZeneca AZN | $8.49 B | -1,707.03% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $7.53 B | -1,525.43% | ๐ฌ๐ง UK |
Sarepta Therapeutics
SRPT | -$0.53 B | -1.61% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | -$0.15 B | -73.13% | ๐บ๐ธ USA |
Agenus
AGEN | -$0.16 B | -69.82% | ๐บ๐ธ USA |
NanoViricides NNVC | -$9.36 M | -98.23% | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | -$0.23 B | -57.20% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | -$0.65 B | 21.79% | ๐บ๐ธ USA |